Biocryst Pharmaceuticals Inc (BCRX)
SG&A Expense Growth
-32.34%
Quarterly · Period ending:
BCRX SG&A Expense Growth
Latest reported-32.34%period ending
Latest reported-32.34%period ending
BCRX Quarterly SG&A Growth (QoQ) (0.00% → -32.34%)
Latest values, visible window
High-resolution chart · PNG
BCRX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 17.0501% | |
| -21.7373% | |
| 33.1814% | |
| -19.1562% | |
| -38.569% | |
| 137.9365% | |
| -14.2857% | |
| -22.2222% | |
| 12.5% | |
| 33.3333% | |
| -50% | |
| 71.4286% | |
| 16.6667% | |
| 0% | |
| 20% | |
| -50% | |
| 42.8571% | |
| 16.6667% | |
| 20% | |
| -54.5455% | |
| 120% | |
| -28.5714% | |
| 40% | |
| 0% | |
| -16.6667% | |
| 50% | |
| 0% | |
| -33.3333% | |
| 20% | |
| 0% |